Trial · NCT02219100
Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus
NCT02219100, Not applicable, Completed, Gynuity Health Projects
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus. Trials, record NCT02219100. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02219100
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus
- NCT number
- NCT02219100
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 613 participants, actual
- Lead sponsor
- Gynuity Health Projects
- Conditions
- Abortion, First Trimester
- Interventions
- Home administration of 200 mg mifepristone
- First posted
- 2014-08-18
- Last updated
- 2014-08-19
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of abortions that are complete without surgical intervention (unit: percent). | 15 days | Percentage of women with complete abortion without the need of a surgical intervention. |
| Secondary | Proportion of women satisfied with procedure (unit: percent) and with side effects (unit: percent). | 15 days | Woman's satisfaction with her medical abortion procedure and side effects experienced. |
| Other | Proportion of Women Who Select Home-use of Mifepristone | 1 week | |
| Other | Proportion of Women Who Select Home-use of Misoprostol | 1 week |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02219100
GET https://conductscience.org/api/trials/v1/NCT02219100/registered